8:30

Contact lenses. Alex Hui,1,2 Centre for Ocular Research and Education, University of Waterloo, Waterloo, Ontario, Canada,1 School of Optometry and Vision Science, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.2

8:45

Cosmetics. Rachna Murthy, FaceRestoration, London, UK

9:00

Digital eye strain. Laura E Downie, University of Melbourne, Australia

9:15

Environmental conditions. Monica Alves, Department of Ophthalmology and Otorhinolaryngology, University of Campinas, Campinas, Brazil.

9:30

Nutrition. Marc Labetoulle, Bicetre-Paris Saclay and Quinze-Vingt Hospitals, Paris, France

9:45

Lifestyle. Michael T. M. Wang1 and Anat Galor,2 Department of Ophthalmology, New Zealand National Eye Centre, The University of Auckland, Auckland, New Zealand,1 and Bascom Palmer Eye Institute, Miami, FL, USA2

10:00

Poster Session I (with Coffee & Tea)

10:50

Uncorrected refractive error. Michele Lanza, Università degli Studi della Campania Luigi Vanvitelli

11:05

Keratoconus. Namrata Sharma, Aafreen Bari, All India Institute of Medical Sciences, New Delhi, India

11:20

Dry eye disease. Jelle Vehof, Department of Twins Research and Genetic Epidemiology, King's College London, London, United Kingdom, and Department of Ophthalmology, University of Groningen, Groningen, Netherlands, and Department of Ophthalmology, Vestfold Hospital Trust, Tønsberg, Norway

11:35

Ocular allergy. Andrea Leonardi, Department of Neuroscience, Ophthalmology Unit, University of Padova, Padova, Italy

11:50

Fuchs’ endothelial dystrophy and corneal diseases. Jodhbir Mehta, Singapore National Eye Centre and Singapore Eye Research Institute

12:05

Pterygium. José Gomes, Ophthalmology Department, Universidade Federal de São Paulo, São Paulo, Brazil

12:20

Poster Viewing & Lunch

13:40

Role of mitochondria in dry eye disease. Wei Chen, Qinxiang Zheng, Dan Jiang, Ling Li, Fanli Peng, National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University1, Wenzhou, China

13:55

Ectodysplasin a mutation: a model for meibomian gland dysfunction and corneal epithelial abnormalities. Shangkun Ou,1,2 Wei Li,2 Department of Ophthalmology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China1. Eye Institute of Xiamen University and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, China2

14:10

Development and application of a human corneal endothelial cell model. Francisco Bandeira e Silva, Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil

14:25

Proteomic analysis of intrinsically disordered proteins in the human tear film. David J. Taylor Gonzalez1, Mak Djulbegovic2, Michael Antonietti3, Anat Galor3, Vladimir N. Uversky4, Carol L. Karp3, 1Hamilton Eye Institute, 2 Wills Eye Hospital, 3 Bascom Palmer Eye Institute, 4 Molecular Medicine and USF Health Byrd Alzheimer's Center and Research Institute

14:40

Tear film microRNAs as potential biomarkers. Garrett N. Jones1, Jeremy Altman1, Drew Mayernik,1 Tae-Jin Lee,1 Shruti Sharma,1,2 Ashok Sharma,1,2 1Center for Biotechnology and Genomic Medicine, 2Department of Ophthalmology, Augusta University, Augusta, GA, USA

14:55

Biochemical, molecular, and genetic biomarkers in the tear film of glaucoma patients. Maria Dolores Pinazo-Durán, Ophthalmic Research Unit “Santiago Grisolía”/FISABIO, and University of Valencia Research Group on Cellular and Molecular Ophthalmo-biology. Valencia, Spain.

15:10

Poster Session I (with Coffee & Tea)

16:00

Epidemiology and pathophysiology of glaucoma. Gus Gazzard, Glaucoma Service, Moorfelds Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; and NIHR-Moorfelds Biomedical Research Centre, London, UK

16:15

Prevalence of, and risk factors for, ocular surface disease in glaucoma patients. Elisabeth M. Messmer, Department of Ophthalmology, LMU University Hospital, München, Germany

16:30

Adverse effects of active ingredients in glaucoma medications on the ocular surface, adnexa, nasolacrimal duct, and periorbital area. Raul E. Ruiz-Lozano, Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA

16:45

Adverse effects of additives in glaucoma medications. Miriam Kolko, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, and Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark

17:00

Management of ocular surface disease in glaucoma patients. Christophe Baudouin, Quinze-Vingts Hospital & Vision Institute, Paris, France

17:15

Management of glaucoma in ocular surface disease patients. Barbara Cvenkel, Department of Ophthalmology, UMC Ljubljana, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

18:00

Introduction, Rolando Toyos (USA)

18:05

ESSIRI (USA; www. eyesarethestory.com), Amy Gallant Sullivan, Founder, and Rachna Murthy, Medical Advisory Board

18:12

Aston Vision Sciences (UK; www.astonvisionsciences.com), Karl Obszanski, Founder

18:19

Photon Therapeutics (New Zealand; www.photon-therapeutics.com), Simon Dean, Co-Founder

18:26

Signal12 (USA; www.signal12inc.com), Pamela Gallin, Medical Director

18:33

ECI Therapeutics (USA; www.ecitherapeutics.com), Ronald Gentile, Co-Founder & Chief Medical Officer

18:40

Azura (Israel; www.azuraophthalmics.com), Marc Gleeson, Chief Executive Officer

18:47

Lµbris BioPharma (USA; www.lubris.net), Benjamin D Sullivan, Co-Founder

8:00

Seeing art through different eyes. Deborah Tramentozzi, Italy

8:15

The vision of individuals with visual impairment and blindness. Lotfi B. Merabet, Laboratory for Visual Neuroplasticity, Massachusetts Eye and Ear, and Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA, USA

8:30

Prevalence of meibomian gland dysfunction in adults. Fiona Stapleton, UNSW Sydney, NSW, Australia

8:45

Prevalence of meibomian gland atrophy in a pediatric population. Preeya K. Gupta, Triangle Eye Consultants, Raleigh, NC, USA

9:00

Hyperlipidemia induces meibomian gland dysfunction. Jinghua Bu1, Minjie Zhang1, Yang Wu1,2, Nan Jiang1, Yuli Guo1, Xin He1, Hui He1, M. Vimalin Jeyalatha1, Zuguo Liu1,3, Wei Li1,3. Department of Ophthalmology, Xiang’an Hospital of Xiamen University; Eye Institute of Xiamen University; School of Medicine, Xiamen University1. Xiamen branch, Zhongshan Hospital, Fudan University2. Xiamen University affiliated Xiamen Eye Center, Xiamen, China 3.

9:15

Advances in meibography for the diagnosis of meibomian gland dysfunction. Reiko Arita, Department of Ophthalmology, Itoh Clinic, Saitama, Japan?

9:30

Intense pulsed light therapy for meibomian gland dysfunction and dry eye disease. Jose Benitez-del-Castillo. University Complutense, HCSC, Clinica Rementeria, Madrid, Spain.

9:45

Hypoxia: a breath of fresh air for optimal meibomian gland function. Shan Yang2, Yaoyao Ren1, Wenjing Li1, Yang Liu,1 1Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China, 2Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

10:00

Poster Session II (with Coffee & Tea)

10:50

Introduction - Victor L Perez. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Florida, USA  

10:55

Definition, classification and diagnosis of dry eye disease - James Wolffsohn. College of Health and Life Sciences, Aston University, Birmingham, UK  

11:10

Management and therapy of dry eye disease - Lyndon Jones. Centre for Ocular Research & Education, School of Optometry & Vision Science, University of Waterloo, Canada  

11:25

TFOS DEWS III Digest - Fiona Stapleton. School of Optometry and Vision Science, UNSW Sydney, NSW, Australia.

11:40

Delphi panel initiative - Jennifer Craig. Department of Ophthalmology, The University of Auckland, Auckland, New Zealand

11:55

Discussion

12:20

Poster Viewing & Lunch

13:40

Convergence of artificial intelligence and microelectronics with ocular surface biology and disease. Dimitri Azar, University of Illinois College of Medicine, Chicago, IL, USA

13:55

Disruptive contact lens technologies. Philip B. Morgan, Eurolens Research, Division of Pharmacy and Optometry, University of Manchester, United Kingdom

14:10

Human ocular mucins and beyond. Pablo Argüeso. Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA

14:25

Importance of circadian rhythms in the ocular surface. Ying Jie, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, No.1 Dong Jiao Min Xiang, Dong Cheng District, Beijing, China

14:40

Obstructive sleep apnea affects lacrimal gland function. Shaopan Wang1,2,8, Xin He1,2,3, Qingmin Li4, Yuhan Zhang1,2, Jiaoyue Hu1,2,5,6, Rongrong Zong1,2, Jingyi Zhuang3, Andrew J. Quantock7, Yingying Gao4*, Wei Li1,2,5,6*, Zuguo Liu1,2,5,6 1Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China, 2Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen University, 3Department of Ophthalmology, the First Affiliated Hospital of Xiamen University, 4Department of Ophthalmology, the Second Affiliated Hospital, Fujian Medical University, Quanzhou, Fujian, China, 5Department of Ophthalmology, Xiang’an Hospital of Xiamen University, 6Xiamen University Affiliated Xiamen Eye Center, Xiamen University. 7School of Optometry and Vision Sciences, Cardiff University, Cardiff, Wales, United Kingdom. 8Institute of Artificial Intelligence, Xiamen University

14:55

Novel role of lymphatic vessels in the pathogenesis of ocular surface disease. Claus Cursiefen, Department of Ophthalmology, University of Cologne and University Hospital Cologne, Koln, Germany

15:10

Poster Session II (with Coffee & Tea)

16:00

The coming revolution in the management of microbial keratitis. James Chodosh.1,2,3 Departments of Ophthalmology and Visual Sciences,1 Molecular Genetics and Microbiology,2 and Neurosciences,3 University of New Mexico School of Medicine, Albuquerque, NM, USA

16:15

Improving outcomes in acute ocular burns. Geetha Iyer, Code Eye Care, Chennai, India 

16:30

Ocular graft versus host disease. Victor L Perez, Robert Levy, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Florida, USA

16:45

Stevens Johnson syndrome/toxic epidermal necrolysis. Haji Saeed, llinois Eye and Ear, Department of Ophthalmology, University of Illinois at Chicago, Chicago, IL; Department of Ophthalmology, Loyola University Medical Center, Maywood, IL, Harvard Medical School, Boston, MA USA 

17:00

Neurotrophic keratopathy. Harminder Singh Dua, University of Nottingham and Queens Medical Centre, Nottingham, England, United Kingdom

17:15

Ocular surface squamous neoplasia: What is new and exciting! Carol L. Karp, Bascom Palmer Eye Institute, Miami, FL, USA

8:30

The promise and challenge of stem cells in regenerative medicine. Graziella Pellegrini, Centre for Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

8:45

Homeostasis of the corneal stem cell niche from a single cell analysis prospective. Joseph Collin1, Rachel Queen1, Darin Zerti 1, Sanja Bojic1, Birthe Dorgau1, Marina Moya Molina1, Chunbo Yang1, Francisco Figueiredo 1,2, Lyle Armstrong1and Majlinda Lako1 Biosciences Institute, Faculty of Medical Sciences, Newcastle University, UK1. UK Department of Ophthalmology, Royal Victoria Infirmary and Newcastle University, Newcastle, UK2

9:00

Mapping the limbal stem cell niche and limbal stem cell deficiency in animal models. Nick Di Girolamo. School of Biomedical Sciences, University of New South Wales, Sydney, Australia.

9:15

Diagnosis and staging of limbal stem cell deficiency. Sophie Deng, Stein Eye Institute, University of California, Los Angeles, CA

9:30

Advances in the treatment of limbal stem cell deficiency. Sayan Basu, Centre for Ocular Regeneration, L V Prasad Eye Institute, Kallam Anji Reddy Campus, L V Prasad Marg, Hyderabad, India

9:45

Bioengineered corneal constructs. May Griffith,1,2,* Mostafa Zamani-Roudbaraki,1,2 Michel Haagdorens,1,3 Hamid Goodarzi,1,2 Isabelle Brunette,1,2 Christos Boutopoulos,1,2,* Marie-Claude Robert1,3,*. Dept. of Ophthalmology, Université de Montréal,1 Maisonneuve-Rosemont Hospital Research Centre,2 Centre hospitalier de l'Université de Montréal,3 Montreal, QC, Canada. *, equivalent contributions

10:00

Poster Session III (with Coffee & Tea)

10:50

Refractive surgery-induced dry eye disease. Ikuko Toda. Minamiaoyama Eye Clinic, Tokyo, Japan

11:05

Cataract surgery-induced dry eye disease. Edoardo Villani, Department of Clinical Science and Community Health, University of Milan. Eye Clinic San Giuseppe Hospital, IRCCS Multimedica, Milan, Italy

11:20

An algorithm for the preoperative diagnosis and treatment of ocular surface disease in refractive surgery patients. Christopher E. Starr, Weill Cornell Medical Center, New York, NY, USA

11:35

Iatrogenic ocular surface diseases after surgery for ocular tumors. Giuseppe Giannaccare, Eye Clinic, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy

11:50

Impact of posterior segment surgery on the ocular surface. Marco Coassin, Vincenzo Barone. Ophthalmology, University Campus Bio-Medico, Rome, Italy.

12:05

Impact of intravitreal injections on the ocular surface. Dot Corinne, Verrecchia Sarah, Chirpaz Nicolas, Billant Jeremy, Chudzinski Roman, Gilli Christelle, Elbany Sandra, Burillon Carole, University Hospital of E. Herriot, Lyon, France

12:20

Poster Viewing & Lunch

13:40

What is neuropathic pain, and what are the underlying mechanisms? Anat Galor, Bascom Palmer Eye Institute, Miami, FL, USA

13:55

Management of neuropathic pain. Pedram Hamrah, Center for Translational Ocular Immunology and Cornea Service, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA

14:10

Depletion of dendritic cells in the quiescent cornea alters sensory nerve activity. Juana Gallar,1,2 Laura Frutos-Rincón,1 M. Carmen Acosta1 1Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain. 2ISABIAL, Alicante, Spain

14:25

What damages corneal nerves in dry eye? Jeremias G. Galletti. Institute of Experimental Medicine, Buenos Aires, Argentina

14:40

Corneal neurotization: indications, surgical techniques and outcomes. Roberto Pineda, Department of Ophthalmology, Harvard Medical School, and Cornea and Refractive Surgery Service, Massachusetts Eye and Ear, Boston, USA

14:55

Poster Session III (with Coffee & Tea)

15:45

New insights into the identification and role of the microbiome. François Majo, Lausanne University, Lausanne, Switzerland 

16:00

Exposomes, microbiome and ocular surface disease. Louis Tong, Hon Shing Ong, Singapore National Eye Center, SIngapore Eye Research Institute

16:15

Ocular surface microbiota in naïve keratoconus: a multicenter validation study. Rocha-de-Lossada C, 1,2,3 Mazzotta C, 4,5,6 Gabrielli F, 7 Papa FT,7 Gómez-Huertas C,8 García-López C,8 Urbinati F,3 Rachwani-Anil R,9 García-Lorente M,9 Sánchez-González JM, 10 Rechichi M,11 Rubegni G,6 Borroni D.1 1Eyemetagenomics Ltd., London UK. 2Ophthalmology Department, QVision, Almeria, Spain. 3Ophthalmology Department, Hospital Regional Universitario Málaga, Malaga, Spain. 4Siena Crosslinking Center, Siena, Italy. 5Department of Ophthalmology Unit, USL Toscana Siena, Italy. 6Postgraduate Ophthalmology School, University of Siena, Siena, Italy. 7Biolab SRL, Laboratorio di Genetica e Genomica Molecolare, Ascoli Piceno, Italy. 8Department of Ophthalmology, Hospital Universitario Virgen de las Nieves, Granada, Spain. 9Department of Ophthalmology, Hospital de Antequera, Malaga, Spain. 10Department of Physics of Condensed Matter, Optics Area, University of Seville, Seville, Spain. 11Centro Polispecialistico Mediterraneo, Sellia Marina, Italy

16:30

Ocular microbiome changes in dry eye disease. Jerome Ozkan. School of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia

16:45

Role of nerve-associated TRPV1 and TRPA1 in resisting bacterial adhesion to the corneal surface. Fleiszig SMJ1 and Evans DJ. 1,2 Herbert Wertheim School of Optometry & Vision Science, University of California, Berkeley, CA;1 College of Pharmacy, Touro University California, Vallejo, CA,2 USA

17:00

The gut-eye-microbiome axis in Sjögren disease. Laura Schaefer1,2, Kaitlin K. Scholand2,3, Vivien J. Coulson-Thomas4, Stephen C. Pflugfelder2, Robert A. Britton1, Cintia S. de Paiva2,3 1Center of Metagenomics and Microbiome Research, BCM, Houston, TX  2Ocular Surface Center, BCM, Houston, TX 3Biochemistry and Cell Biology Graduate Program, Rice University, Houston, TX  4University of Houston, Houston, TX